Full-Time

Sr. Director

Quality Control

Confirmed live in the last 24 hours

ProKidney

ProKidney

51-200 employees

Develops cell therapy for chronic kidney disease

Biotechnology
Healthcare

Senior, Expert

Winston-Salem, NC, USA

Category
Biology Lab & Research
Biology & Biotech
Requirements
  • A bachelor’s degree in biology, biochemistry, immunology, or molecular and cellular biology is required. An advanced degree or Ph.D. in a scientific/technical discipline is preferred.
  • 10+ years of experience in GMP regulated biopharmaceutical industry, including 10+ years in a management/leadership role. Advance or Ph.D. degree preferred.
  • Technical and regulatory understanding of biologics, gene, or cell therapy QC with an understanding of the control strategy for these drug classes.
  • Ability to work in a fast-paced and dynamic environment that will require management of multiple competing priorities while driving all projects forward and meeting program/project deliverables.
  • Strong leadership, collaboration, team building, program management and organizational skills.
  • Proven ability to develop, communicate, and execute plans and strategies with a wide range of stakeholders.
  • Excellent judgment and creative problem-solving skills, including negotiation and conflict resolution skills.
  • Excellent interpersonal, organizational, and written and oral communication skills.
  • Prior experience in a managerial capacity within QA or QC.
  • Communicate effectively and successfully handle conflict resolution.
  • Possess experience with laboratory operations, analytical transfer and validation, Pre-Approval Inspections, and product launch activities.
  • Advanced knowledge of GMPs.
  • Experience ensuring all laboratory investigations meet compliance requirements.
Responsibilities
  • Directs the development, validation, planning, implementation, and maintenance of QC product tests and analytical methods, processes, and operations.
  • Supports the design and execution of the environmental monitoring and sterility assurance programs for GMP manufacturing operations.
  • Supports development of QC tests and analytical methods that support production, including design support.
  • Validates analytical test methods for raw materials and finished goods.
  • Oversees raw material, in-process and final product release testing.
  • Responsible for ensuring the appropriate stability programs are initiated and completed to support product development and customer requirements.
  • Ensures quality control systems and equipment are compliant with standards and applicable regulatory guidelines.
  • Responsible for ensuring that project objectives are met & continuous improvement of the Analytical Laboratories.
  • Strong scientific background and experience with cellular therapies across a broad range of cell types and disease treatments (adult-derived cells, stem cells, immune cells. allogeneic, autologous, etc.).
  • Familiarity with applicable regulatory requirements and compendia concerning cGMP manufacturing and testing of human cells (21CFR210, 211, 820 and 1271; Eudralex, USP, EP and ICH).
  • Understanding of analytical method qualification and validation per USP, EP and ICH guidelines.
  • Responsible for developing and delivering training materials to ensure that all QC employees' operational, scientific, and analytical training is conducted as needed to ensure that the group is entirely and accurately trained on time for all QC activities.
  • Responsible for liaison with the Manufacturing, Quality Assurance, Supply Chain, Project Management, Facilities, and other GMP Quality Control units.
  • Provide support in resolving issues to meet project goals and deliverables.
  • Serves as primary QC contact for regulatory inspections.
  • Leads and participates in projects within the organization's objectives and project timelines and participates in cross-functional projects as the quality control subject matter expert.
  • Hires, manages, and trains staff. Plans and assigns duties to meet departmental and organizational objectives. Provides guidance and direction to staff, including appropriate training, mentoring, and development of staff.
  • Mentor’s direct reports and guide them to the next level in their careers.
  • Is the primary point of contact and SME for analytical testing and provides guidance aligned with regulatory standards and good laboratory practices.

ProKidney focuses on developing a new treatment for Chronic Kidney Disease (CKD) using a cell therapy called rilparencel. This therapy aims to help preserve kidney function in patients with advanced CKD, potentially delaying or eliminating the need for dialysis, which is often the only option for these patients. ProKidney is currently in the late stages of clinical trials, and early results indicate that rilparencel may effectively maintain kidney function. What sets ProKidney apart from its competitors is its specific focus on CKD and its unique approach to treatment through cell therapy, targeting a significant and underserved patient population. The company's goal is to provide a new therapeutic option that can improve the quality of life for millions of CKD patients, ultimately transforming their treatment experience.

Company Stage

IPO

Total Funding

$559.3M

Headquarters

Winston-Salem, North Carolina

Founded

2015

Growth & Insights
Headcount

6 month growth

20%

1 year growth

40%

2 year growth

112%
Simplify Jobs

Simplify's Take

What believers are saying

  • ProKidney raised $140 million, boosting its CKD therapeutic developments.
  • The FDA's favorable stance on cell therapies supports rilparencel's potential approval.
  • CKD treatment market is projected to grow at a 6.5% CAGR until 2028.

What critics are saying

  • ProKidney canceled a $485 million Greensboro expansion, indicating potential strategic instability.
  • Recent CEO appointment suggests possible internal management challenges.
  • Increased manufacturing expenses could strain financial resources if rilparencel revenue is delayed.

What makes ProKidney unique

  • ProKidney is pioneering rilparencel, a novel cell therapy for CKD treatment.
  • The company targets an underserved market segment, offering alternatives to dialysis.
  • ProKidney's focus on preserving kidney function sets it apart in the biotech industry.

Help us improve and share your feedback! Did you find this helpful?